focus -WSS

focus

author：comprehensive 2025-09-06 03:58:31 - browse：76

Adam's take main illustration — Molly Ferguson/STAT

It took Anavex Life Sciences seven months to finally acknowledge the failure of a late-stage clinical trial in Rett syndrome.

The negative study outcome was never in doubt, so the only surprise from Tuesday’s announcement was the company’s lame attempt at damage control. Anavex is a serial dissembler of clinical trial results, so I was expecting better spin. Instead, management barely tried, which tells you the real results from the Rett study must be truly awful.

Anavex shares fell 31% to $6 in early trading. The company’s only drug in clinical development, called blarcamesine, is a zero. Rett is the latest failure, following earlier study failures in Alzheimer’s disease and Parkinson’s disease. Yet even with Tuesday’s drop in share price, Anavex still carries a fully diluted market value of nearly $650 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Rare Northern Lights show in US this week: Where and how to see it

WSS

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

Hospitals are dialing back on venture capital investing

House panel to mark up pandemic

How corporate America is slashing DEI workers amid backlash to diversity programs

Senators push IRS to launch nonprofit hospital probe

What are cluster munitions? Biden defends decision to send controversial weapons to Ukraine

focus

focus

Wikipedia

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

After Optum profits sink, UnitedHealth makes changes

Psychedelics group wrestles with new pharma identity

Novo Nordisk touts Wegovy study, but still struggling with supply

Drug repurposing or repositioning? The language matters

What to know about a major upcoming Wegovy heart health study

What does generative AI mean for health care? We asked experts

Timeline: How the deadly wildfires took over Maui day by day

focus

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

What could happen if Russia blows up the Zaporizhzhia Nuclear Power Plant?

Father who lunged at Larry Nassar comforted by deputy who pinned him down: 'I understand'

Indictment alleges Trump's ex

Neutralizing antibodies against HIV shows promise in children

Be careful with at

knowledge

hotspot

entertainment

Wikipedia